MARANDA NEAL: Open Payments
NPI 1558925230 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$418 in 17 payments from 12 companies in 2025. Trend: 2023 $105 · 2024 $219 · 2025 $418
Food & beverage: $418
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 1 | $76 |
| Sumitomo Pharma America, Inc. | 3 | $71 |
| PFIZER INC. | 2 | $61 |
| ABBVIE INC. | 2 | $34 |
| Dendreon Pharmaceuticals LLC | 1 | $29 |
| 180 Medical, Inc. | 2 | $28 |
| Procept Biorobotics Corporation | 1 | $27 |
| ABC Home Medical Supply, Inc. | 1 | $24 |
| Janssen Biotech, Inc. | 1 | $21 |
| Pacira Pharmaceuticals Incorporated | 1 | $19 |
Products named: GEMTESA, XTANDI, LUPRON DEPOT, RUBRACA, PROVENGE, AQUABEAM ROBOTIC SYSTEM, ERLEADA, Exparel.
Industry payments across TX — which companies pay providers there.
